Stryker Corp (SYK)
Summary
SYK Chart
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference
Portage, Michigan, April 29, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2025 Global Healthcare Conference on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Preston Wells, Vice President and Chief Financial Officer, and Jason Beach, Vice President, Finance and Investor Relations.
Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stryker Corp Dividends
| SYK 4 weeks ago Announced | Quarterly | $0.84 Per Share |
| SYK 3 months ago Paid | Quarterly | $0.84 Per Share |
| SYK 6 months ago Paid | Quarterly | $0.8 Per Share |
| SYK 10 months ago Paid | Quarterly | $0.8 Per Share |
| SYK 27 Mar 2024 Paid | Quarterly | $0.8 Per Share |
Stryker Corp Earnings
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 28 Jan 2025 Date | | 3.87 Cons. EPS | 4.01 EPS |
| 31 Oct 2024 Date | | 2.77 Cons. EPS | - EPS |
| 29 Oct 2024 Date | | 2.77 Cons. EPS | 2.87 EPS |
| 1 Aug 2024 Date | | 2.79 Cons. EPS | - EPS |
| SYK 4 weeks ago Announced | Quarterly | $0.84 Per Share |
| SYK 3 months ago Paid | Quarterly | $0.84 Per Share |
| SYK 6 months ago Paid | Quarterly | $0.8 Per Share |
| SYK 10 months ago Paid | Quarterly | $0.8 Per Share |
| SYK 27 Mar 2024 Paid | Quarterly | $0.8 Per Share |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 28 Jan 2025 Date | | 3.87 Cons. EPS | 4.01 EPS |
| 31 Oct 2024 Date | | 2.77 Cons. EPS | - EPS |
| 29 Oct 2024 Date | | 2.77 Cons. EPS | 2.87 EPS |
| 1 Aug 2024 Date | | 2.79 Cons. EPS | - EPS |
Stryker Corp (SYK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Stryker Corp ever had a stock split?
Stryker Corp Profile
| Medical Devices Industry | Healthcare Sector | Mr. Kevin A. Lobo CEO | NYSE Exchange | US8636671013 ISIN |
| United States Country | 52,000 Employees | - Last Dividend | 17 May 2004 Last Split | - IPO Date |
Overview
Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.
Products and Services
Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:
- Orthopaedics and Spine: This involves providing implants used in total joint replacements for hip, knee, and shoulder surgeries, along with trauma and extremities surgeries. The segment is also known for its spinal implant products, which consist of systems for cervical and thoracolumbar applications, including fixation, minimally invasive, and interbody systems targeted at spinal injury, complex spine, and degenerative therapies.
- MedSurg and Neurotechnology: A broad range of surgical equipment and surgical navigation systems fall under this segment, alongside endoscopic and communications systems. Stryker also offers products aimed at enhancing patient handling, emergency medical care, and intensive care through disposable products, reprocessed and remanufactured medical devices. Additionally, clinical communication and workflow solutions, along with a variety of medical device products for different specialties, are provided, focusing on patient and caregiver safety technologies.
- Neurosurgical, Neurovascular, and Craniomaxillofacial Implant Products: This category includes products for minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and biosurgery products like synthetic bone grafts and vertebral augmentation products. For the treatment of acute ischemic and hemorrhagic stroke, minimally invasive products are offered. The segment also covers craniomaxillofacial implant products, including devices for cranial, maxillofacial, and chest wall surgeries, as well as dural substitutes and sealants.
These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.
Contact Information
